Tiktok To Launch Live Shopping In U.S. Using Outsourced Technology

-FT https://www.ft.com/content/479cd8da-c416-456d-a2a2-533af8a5b7bb

-FT

https://www.ft.com/content/479cd8da-c416-456d-a2a2-533af8a5b7bb

Total
0
Shares
Related Posts
Read More

AstraZeneca Announced Enhertu Showed Clinically Meaningful And Durable Responses Across Multiple HER2-Expressing Tumor Types In DESTINY-PanTumor02 Phase II Trial

Positive high-level results from an analysis of the ongoing DESTINY-PanTumor02 Phase II trial showed AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) met the prespecified target for objective response rate (ORR) and demonstrated durable response across multiple HER2-expressing advanced solid tumours in heavily pretreated patients.

AZN